262 related articles for article (PubMed ID: 29337144)
1. Early activation of Egr-1 promotes neuroinflammation and dopaminergic neurodegeneration in an experimental model of Parkinson's disease.
Yu Q; Huang Q; Du X; Xu S; Li M; Ma S
Exp Neurol; 2018 Apr; 302():145-154. PubMed ID: 29337144
[TBL] [Abstract][Full Text] [Related]
2. Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes.
Parillaud VR; Lornet G; Monnet Y; Privat AL; Haddad AT; Brochard V; Bekaert A; de Chanville CB; Hirsch EC; Combadière C; Hunot S; Lobsiger CS
J Neuroinflammation; 2017 Mar; 14(1):60. PubMed ID: 28320442
[TBL] [Abstract][Full Text] [Related]
3. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
4. Effect of NAC treatment and physical activity on neuroinflammation in subchronic Parkinsonism; is physical activity essential?
Gil-Martínez AL; Cuenca L; Sánchez C; Estrada C; Fernández-Villalba E; Herrero MT
J Neuroinflammation; 2018 Nov; 15(1):328. PubMed ID: 30477535
[TBL] [Abstract][Full Text] [Related]
5. JNK-mediated activation of ATF2 contributes to dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease.
Huang Q; Du X; He X; Yu Q; Hu K; Breitwieser W; Shen Q; Ma S; Li M
Exp Neurol; 2016 Mar; 277():296-304. PubMed ID: 26515688
[TBL] [Abstract][Full Text] [Related]
6. Phloretin attenuates behavior deficits and neuroinflammatory response in MPTP induced Parkinson's disease in mice.
Zhang G; Yang G; Liu J
Life Sci; 2019 Sep; 232():116600. PubMed ID: 31251998
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH
Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
[TBL] [Abstract][Full Text] [Related]
9. The α7 nAChR agonist PNU-282987 reduces inflammation and MPTP-induced nigral dopaminergic cell loss in mice.
Stuckenholz V; Bacher M; Balzer-Geldsetzer M; Alvarez-Fischer D; Oertel WH; Dodel RC; Noelker C
J Parkinsons Dis; 2013; 3(2):161-72. PubMed ID: 23938346
[TBL] [Abstract][Full Text] [Related]
10. Dynamic changes of activated AHR in microglia and astrocytes in the substantia nigra-striatum system in an MPTP-induced Parkinson's disease mouse model.
Zhou Y; Zhao WJ; Quan W; Qiao CM; Cui C; Hong H; Shi Y; Niu GY; Zhao LP; Shen YQ
Brain Res Bull; 2021 Nov; 176():174-183. PubMed ID: 34478811
[TBL] [Abstract][Full Text] [Related]
11. Preferential Heme Oxygenase-1 Activation in Striatal Astrocytes Antagonizes Dopaminergic Neuron Degeneration in MPTP-Intoxicated Mice.
Xu X; Song N; Wang R; Jiang H; Xie J
Mol Neurobiol; 2016 Oct; 53(8):5056-65. PubMed ID: 26385576
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice.
Samantaray S; Knaryan VH; Shields DC; Cox AA; Haque A; Banik NL
Mol Neurobiol; 2015 Oct; 52(2):1054-66. PubMed ID: 26108182
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of acetyl-l-carnitine (ALC) in a chronic MPTP-induced Parkinson's disease mouse model: Endothelial and microglial effects.
Burks S; Raymick J; Robinson B; Hanig J; Sarkar S
Neurosci Lett; 2019 Jun; 703():86-95. PubMed ID: 30890473
[TBL] [Abstract][Full Text] [Related]
14. Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
Karunakaran S; Saeed U; Mishra M; Valli RK; Joshi SD; Meka DP; Seth P; Ravindranath V
J Neurosci; 2008 Nov; 28(47):12500-9. PubMed ID: 19020042
[TBL] [Abstract][Full Text] [Related]
15. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
[TBL] [Abstract][Full Text] [Related]
16. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets.
Corwin C; Nikolopoulou A; Pan AL; Nunez-Santos M; Vallabhajosula S; Serrano P; Babich J; Figueiredo-Pereira ME
J Neuroinflammation; 2018 Sep; 15(1):272. PubMed ID: 30236122
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model.
Li Y; Liu W; Li L; Hölscher C
Neuropharmacology; 2016 Feb; 101():255-63. PubMed ID: 26453962
[TBL] [Abstract][Full Text] [Related]
19. Eupatilin prevents behavioral deficits and dopaminergic neuron degeneration in a Parkinson's disease mouse model.
Zhang Y; Qin L; Xie J; Li J; Wang C
Life Sci; 2020 Jul; 253():117745. PubMed ID: 32376269
[TBL] [Abstract][Full Text] [Related]
20. Neural Stem Cell Grafts Promote Astroglia-Driven Neurorestoration in the Aged Parkinsonian Brain via Wnt/β-Catenin Signaling.
L'Episcopo F; Tirolo C; Peruzzotti-Jametti L; Serapide MF; Testa N; Caniglia S; Balzarotti B; Pluchino S; Marchetti B
Stem Cells; 2018 Aug; 36(8):1179-1197. PubMed ID: 29575325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
